Request Appointment
12902 Usf Magnolia DrTampa, FL 33612
Fax+1 813-972-7673
Overview of Dr. Kim
Dr. Richard Kim is an oncologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and James A. Haley Veterans' Hospital-Tampa. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 26 years. Dr. Kim accepts several types of health insurance, listed below. He is one of 201 doctors at H. Lee Moffitt Cancer Center and Research Institute and one of 49 doctors at James A. Haley Veterans' Hospital-Tampa who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2001 - 2003
University of Miami Leonard M. Miller School of MedicineClass of 2000
Certifications & Licensure
FL State Medical License 2010 - 2028
OH State Medical License 2006 - 2010
CT State Medical License 2003 - 2006
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2016-2017
Clinical Trials
- Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma Start of enrollment: 2016 Jul 05
- Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma Start of enrollment: 2016 Oct 14
- Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies Start of enrollment: 2020 Oct 12
Publications & Presentations
PubMed
- Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.Sophie Moravec, Laura V Barton, Revathy Suresh, Laura Hayward, Tara Schmidlen
JCO Precision Oncology. 2026-06-01 - A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma.Anthony B El-Khoueiry, Richard D Kim, William P Harris, Max W Sung, Dirk Waldschmidt
Hepatology. 2026-06-01 - 1 citationsPhase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer.Francois Ghiringhelli, Richard Kim, Teresa Macarulla, Irene Moreno, Albiruni Abdul Razak
Journal for Immunotherapy of Cancer. 2026-03-13
Press Mentions
Review in Chinese Medical Journal Spotlights Neoadjuvant Therapy’s Potential in Treating Advanced Colon CancerSeptember 19th, 2025
ctDNA Testing Shows Promise in Guiding CRC Treatment DecisionsJanuary 29th, 2025- ctDNA Testing Shows Promise for Influencing Colorectal Cancer TreatmentJanuary 27th, 2025
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOCoventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Health Net Oregon PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
